Danaher risk/reward 'unusually positive,' says JPMorgan JPMorgan views the current risk/reward on shares of Danaher as "unusually positive" following recent underperformance of the stock. The firm reiterates an Overweight rating on the name with an $85 price target.
Danaher price target raised to $100 from $89 at Jefferies Jefferies raised its price target for Danaher shares to $100 ahead of the company's investor day and keeps a Buy rating on the name. It expects an initial 2015 organic growth outlook of 3% and earnings guidance of $3.95 and ex-amortization $4.40. Jefferies keeps a Buy rating on the stock.